Comparison of immune responses to the PCV2 replicase-capsid and capsid virus-like particle vaccines in mice

• Published in: Journal of microbiology and biotechnology Vol. 29; no. 3; pp. 482 - 488
• Main Authors: Jung, Bo-Kyoung, Kim, Hye-Ran, Lee, Young-Hyeon, Jang, Hyun, Chang, Kyung-Soo
• Format: Journal Article
• Language: English
• Published: Korea (South) 한국미생물·생명공학회 28.03.2019
• Subjects: 생물학; replicase; Porcine circovirus type 2; vaccine; post-weaning multisystemic wasting syndrome; Baculovirus; capsid
• ISSN: 1017-7825; 1738-8872
• DOI: 10.4014/jmb.1809.09032

Porcine circovirus type 2 (PCV2) is the causative agent of postweaning multisystemic wasting syndrome (PMWS). Replicase (Rep) protein is considered essential proteins for viral replication. Capsid (Cap) protein is the primary immunogenic protein that induces protective immunity. Little is known about comparison on the immunogenicity of PCV2 Rep and Cap fusion protein and Cap protein. In the present study, recombinant baculoviruses expressing the Rep-Cap fusion protein (Bac-Rep-Cap) and the Cap protein (Bac-Cap) of PCV2 were constructed and confirmed with western blot and indirect fluorescence assay. Immunogenicities of the two recombinant proteins were tested in mice. The titers of antibodies were determined with a PCV2-specific enzyme-linked immunosorbent assay (ELISA) and a serum neutralization assay. The IFN-γ response immunized mice was measured by ELISA. The mice immunized with the Bac-Rep-Cap and Bac-Cap successfully produced Cap-specific immunoreaction. The mice immunized with the Bac-Cap developed higher PCV2-specific neutralizing antibody titers than mice injected with the Bac-Rep-Cap. IFN-γ in the Bac-Rep-Cap group was increased compared to those in the Bac-Cap group. Vaccination of mice with the Bac-Rep-Cap showed significantly decreased protective efficacy compared to the Bac-Cap. Our findings will indubitably not only lead to a better understanding of the immunogenicity of PCV2, but also improved vaccines.